Search the web
Sign In
New User? Sign Up
FuzeonSupport
  • Members Only
  • Post
  • Files
  • Photos
  • Links
  • Database
  • Polls
  • Calendar
  • Groups Labs (Beta)
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Show off your group to the world. Share a photo of your group with us.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

   Messages Help
Message #
Search:
Advanced
TMC 114 protease inhibitor- Expanded Access Information   Message List  
Reply | Forward Message #763 of 1195 |
This email is from Tibotec
 
We wanted to alert you to the attached press release which will be issued tomorrow morning. The TMC114 EAP (TMC114-C226) is now in the process of being approved and opening throughout the U.S. This is the next phase of the TMC114 early access program which began earlier this year. Further details will be posted to www.clinicaltrials.gov in the near future.

If you are in North America and would like to participate or desire more details, please:

Call: 1-866-889-2074

Email: TMC114-C226@...
Visit: www.Tibotec.com


If you are outside of North America, the Expanded Access/Named Patient programs will open in the first countries next month. For participation or additional information, please:

Email: <mailto:earlyaccess@...>

Visit: www.Tibotec.com

NOTE FROM NELSON VERGEL:  This expanded access program  has a limit of 200 T cells or under. If you do not have any other active medications left in your genotype and you have over 200 T cells, ask your doctor to apply for an exemption.
DO NOT START TMC 114 if you do not have another active medication to start it with. People who started TMC 114 with Fuzeon had the best response to this new protease inhibitor.
 
Also keep in mind that in a few weeks Tibotec will be starting its combination study of TMC 114  (protease) + TMC 125 (non nuke). This is the first time in AIDS history that a company has the chance to start a study of two investigational agents. If you get into the expanded access for TMC 114, you will not be able to participate in this groundbreaking study.  I am looking forward to joining this study myself!

I will be sending an email in the near future summarizing other expanded access programs coming up in the next 12 months. We will have two oral entry inhibitors :Maraviroc and Vicriviroc, and an IV every two weeks: TNX 355. These three compounds may be used with TMC 114 when the time comes, so we will have more options to start two to three new agents. If your T cells are above 250 and are clinically stable and you have multi-drug resistance, you may want to wait until these agents get their expanded access started to have more options for success.
 
 

 


Regards,

Nelson Vergel
Program for Wellness Restoration


 


Disclaimer

This information (and any accompanying printed material) is not intended to replace the attention or advice of a physician or other health care professional. Anyone who wishes to embark on any dietary, drug, exercise, or other lifestyle change intended to prevent or treat a specific disease or condition should first consult with and seek clearance from a qualified health care professional.
Wed Oct 26, 2005 3:04 pm

Show Message Option
nelsonvergel
Offline Offline
Send Email Send Email

Forward 		Message #763 of 1195 |
Expand Messages Author Sort by Date

This email is from Tibotec We wanted to alert you to the attached press release which will be issued tomorrow morning. The TMC114 EAP (TMC114-C226) is now in... 		PoWeRTX@...
nelsonvergel
Offline Send Email 		Oct 26, 2005
3:36 pm
< Prev Topic  |  Next Topic >
Message #
Search:
Advanced
Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help